Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. - Test2 - elhamkhani - TriplyDB

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.

http://www.wikidata.org/entity/Q30846057

about

The role of oxidative stress in Parkinson's disease Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism The ketogenic diet: uses in epilepsy and other neurologic illnesses Dietary factors, hormesis and health The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies Neuroprotective and disease-modifying effects of the ketogenic diet Glutamate and neurotrophic factors in neuronal plasticity and disease Dietary Restriction and Nutrient Balance in Aging Dietary supplementations as neuroprotective therapies: focus on NT-020 diet benefits in a rat model of stroke Metabolomics of human brain aging and age-related neurodegenerative diseases Role of the hypothalamus in mediating protective effects of dietary restriction during aging Dietary factors in the etiology of Parkinson's disease.GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats Energy intake and exercise as determinants of brain health and vulnerability to injury and disease The neurotoxicology of hard foraging and fat-melts Perspective: Does brown fat protect against diseases of aging?Effect of feeding regimens on circadian rhythms: implications for aging and longevity.Age and energy intake interact to modify cell stress pathways and stroke outcome.Recruiting adaptive cellular stress responses for successful brain ageing.The impact of dietary energy intake on cognitive aging.Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines Communication breakdown: the impact of ageing on synapse structure.The Effects of Fasting During Ramadan on the Concentration of Serotonin, Dopamine, Brain-Derived Neurotrophic Factor and Nerve Growth Factor A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys.Dietary restriction mitigates cocaine-induced alterations of olfactory bulb cellular plasticity and gene expression, and behavior.D-β-hydroxybutyrate is protective in mouse models of Huntington's disease.Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys.Successful brain aging: plasticity, environmental enrichment, and lifestyle.Neuronal and cognitive plasticity: a neurocognitive framework for ameliorating cognitive aging.Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism Between destiny and disease: genetics and molecular pathways of human central nervous system aging Caloric restriction and intermittent fasting: two potential diets for successful brain aging.Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease

P2860

Q24307946-0DB0B23E-A471-46F7-A9D4-122DB38EBC39 Q24613339-8A0CAD2C-D45F-4192-9846-B022F0E4F747 Q24617926-8D6DDB3A-22C6-401F-9BE6-9A94008FB9BF Q24644082-830CD1DB-1DD4-49E5-A97C-5250560663F8 Q24646616-5E5C7B15-4B4D-4C46-B869-7BFD6CECD0CB Q24646914-E7178FDC-88E7-4D2F-90C2-98AB56C0EE48 Q24653626-3CB41CBD-E979-4B7A-B0A9-7E7F89EEE96E Q26774911-0FC08997-0F09-433C-B23E-2B5557A82A80 Q26991784-E84C3BA8-648E-4B0F-8B8C-2D406AF92CBA Q26992344-E5C97D78-0BC3-407F-853B-5B6C43F69466 Q27692402-1F22C62C-15B6-4B1B-89A7-9A515AA104D2 Q28085390-DDC41553-0E4C-442D-9FEC-0B2680A3F967 Q28088320-332F9C28-056E-4241-AB88-505FEF569C0C Q28389419-EC853823-559D-4BE7-88AA-730154DF56FD Q28394667-A2A5FC5A-B72D-49DD-AF3D-2704E86FC720 Q28574680-E8730AD8-48C2-499F-9EA0-A1A23D8634A2 Q28583791-97E57409-4814-4864-B767-0D1D3DA22D34 Q28710367-79D3C13B-F8D1-4F35-902C-C73AA472EFAA Q33583355-BDA480C1-C5D3-4ABA-A4AF-FC4418398EBF Q33638841-726AE1F2-7B4B-401B-AAA3-47F713A866BA Q33722180-8542E64C-BF70-4F7B-B44D-3613B713C1EE Q33750504-0ABCF79D-8916-4FEA-852F-0CCE70A8FF92 Q33854353-07D161D5-176F-41E6-A274-56D150A99FEF Q33868403-AC5430ED-ABB2-4CC6-BD76-FCC49FA49142 Q33880898-E685BA5B-213A-4591-B496-70F96E942E8A Q33889358-6EE08C02-A1CF-4D30-AF3C-FFB726DE28B6 Q33893484-81FEE02F-3BBB-408A-A001-C3450C6D5DB0 Q33967886-CBA258AB-7B12-4EB6-93FD-AD5AD8992B68 Q33988290-5EAF32C4-E835-4345-A489-EA660820DDE8 Q34023773-9EB69CA0-5D6C-45AF-AD02-DF63B93F15B3 Q34110183-9CD42F1B-FAFA-4649-8B8C-E0A7B9F0705A Q34142817-38752919-EB37-4F15-B7B7-FC8B4FF296C4 Q34338551-760EB226-6D4F-4668-912B-7E0BB4B4C5FC Q34394701-44B7C677-E1E4-4874-BC92-4CCC65408A54 Q34458952-8F72C5C8-FF8E-4F11-B510-D108C066E0E9 Q34556553-8885A225-BDD7-4012-AA3B-40530EFC8F3F Q34569825-6D1D2C42-3D12-4049-B4FE-AC24ED1CC7A5 Q34594647-A8C0FA53-AA26-4765-AC63-2FE39B753F8E Q34653802-4D8530D0-6BF3-4C27-BFF2-CB28F57A13DD Q34700226-8611FC82-1ACC-4E3C-AA7E-FE15A7DD93B9

P2860

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease.

http://www.wikidata.org/entity/Q30846057

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Caloric restriction increases ...... model of Parkinson's disease.

@ast

Caloric restriction increases ...... model of Parkinson's disease.

@en

type

label

Caloric restriction increases ...... model of Parkinson's disease.

@ast

Caloric restriction increases ...... model of Parkinson's disease.

@en

prefLabel

Caloric restriction increases ...... model of Parkinson's disease.

@ast

Caloric restriction increases ...... model of Parkinson's disease.

@en

P1433

Q30846057-ED2CCDB8-DA3B-412C-869A-5823F964C59B

P1476

Q30846057-3416B70F-72CE-4821-8AAD-25D8F0F0CAD7

P2093

Q30846057-096EC692-4D23-4B16-8264-D0F358C14B22

Q30846057-2A00CBB7-25FF-43F9-9919-B37389594BFA

Q30846057-2BFED100-CE5C-40B3-AF77-99A3AD711D41

Q30846057-43B85C9E-6E02-426F-8458-BF4E995D499F

Q30846057-576A711C-D77D-46EF-BCB8-F6941BC03C9A

Q30846057-59759552-8685-485D-80FC-7E0666DD03E9

Q30846057-5C7FA6CC-96E2-47F9-AB5A-09DF425B8AD5

Q30846057-8DCE1F1B-63C2-4A6C-9DC5-336E06A6447A

Q30846057-AE4F3484-26A1-4522-B80D-084948FA5915

Q30846057-DB1836F6-DD07-46EF-9E7A-AEB204639E03

P2860

Q30846057-0247A9DF-1158-4C74-8937-E2B3A325F3CB

Q30846057-0417BD8C-4580-4DF6-8B91-71A30B72B106

Q30846057-076C2E1D-96A5-47D3-977F-E185625FEDB5

Q30846057-0F2EDB35-FAC3-4AB0-A17C-578FA6738319

Q30846057-150ECC2D-8EBF-489F-BB78-BF138BE366A8

Q30846057-16796C55-BE30-4CA8-9A31-1DAA9FB9B030

Q30846057-185047D0-784A-431D-8110-5B156B0ADF3B

Q30846057-1B6CDE23-9676-445A-8ED2-E7B7975A403F

Q30846057-1B7B5293-E4D9-4268-84BF-5B1766ACCAA6

Q30846057-1BED7B67-8382-4902-96AB-BA5BC616C3CB

P304

Q30846057-F4D6D30E-7FD2-4F56-AD22-77B330BE155D

P31

Q30846057-74C580F6-FAD7-47BC-9CE4-193D0F69DA11

P356

Q30846057-50B8CF1B-58F2-4D88-AABD-206F45C8F285

P407

Q30846057-F6328B27-026F-40BD-A0EF-5D896DCCAF52

P433

Q30846057-E2F7C849-8BB0-4CBD-987E-201584E98D7A

P478

Q30846057-BEC861B3-F286-4501-9E79-D1A114690264

P50

Q30846057-64BA9906-E817-46C5-82A9-FD3033150F2A

P577

Q30846057-EFBD01D0-9D1B-4F3D-B3B0-BC7C9A78501C

P5875

Q30846057-80719AAA-B9F8-4402-9BC7-47D9EBD94830

P698

Q30846057-B816ABCA-16C6-44DF-B6A4-7A0227395A48

P921

Q30846057-A6194F81-B871-4602-82A2-A5D4D42DFFB7

P932

Q30846057-1C750DD2-5A43-4136-9604-165339835B58

P356

PNAS.0405831102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Caloric restriction increases ...... model of Parkinson's disease.

@en

P2093

Christopher Quigley

http://www.w3.org/2001/XMLSchema#string

Don M Gash

http://www.w3.org/2001/XMLSchema#string

Donald K Ingram

http://www.w3.org/2001/XMLSchema#string

Edward Tilmont

http://www.w3.org/2001/XMLSchema#string

George S Roth

http://www.w3.org/2001/XMLSchema#string

Greg A Gerhardt

http://www.w3.org/2001/XMLSchema#string

Jennifer Young

http://www.w3.org/2001/XMLSchema#string

Julie Mattison

http://www.w3.org/2001/XMLSchema#string

Mark A Lane

http://www.w3.org/2001/XMLSchema#string

Navin Maswood

http://www.w3.org/2001/XMLSchema#string

P2860

Functional recovery in parkinsonian monkeys treated with GDNF

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

Parkinson's disease: mechanisms and models

Molecular pathways of neurodegeneration in Parkinson's disease

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.

Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice.

Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging.

What counts in brain aging? Design-based stereological analysis of cell number.

P304

18171-18176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0405831102

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8126105

http://www.w3.org/2001/XMLSchema#string

P698

15604149

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

539733

http://www.w3.org/2001/XMLSchema#string